5-HT 4 receptor agonists Prucalopride, a selective 5-hydroxytryptamine 4 (5-HT 4 ) receptor agonist, was effective in improving symptoms in a cohort with predominantly idiopathic gastroparesis, but despite accelerating gastric emptying in a diabetes-specific group, did not improve symptoms [73]
Front Pharmacol 2021;12:627533
The part that trips people up is that the same medication shows up under different brand names, different doses, and different FDA approvals depending on the goal
[7] [9] Stop the GLP-1 medicine and seek urgent medical evaluation if pancreatitis is suspected
References Bohmer, T., Rydning, A
Archived from the original on 29 August 2020